StockData
Zivo Bioscience, Inc. logo

Zivo Bioscience, Inc. (ZIVO) stock

ZIVOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 1/30
$6.80+0.30 (+4.62%)

Close on Oct 19, 2026Market cap $25.96MP/E –Yield –

Zivo Bioscience total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Zivo Bioscience's total debt was $11.66K at Sep 30, 2025. For fiscal 2024 it was $116.20K. The highest annual figure on record is $121.70K in fiscal 2020.

Annual total debt

PeriodPeriod endValueChange
FY2024Dec 31, 2024$116.20K–
FY2023Dec 31, 2023$0-100.0%
FY2022Dec 31, 2022$105.92K–
FY2021Dec 31, 2021$0-100.0%
FY2020Dec 31, 2020$121.70K–
FY2019Dec 31, 2019$0–
FY2012Dec 31, 2012$0-100.0%
FY2011Dec 31, 2011$7.68K+118.5%
FY2010Dec 31, 2010$3.52K–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2025Sep 30, 2025$11.66K-47.1%
Q1 FY2025Mar 31, 2025$254.45K+399.7%
Q4 FY2024Dec 31, 2024$116.20K+9.7%
Q4 FY2023Dec 31, 2023$0-100.0%
Q3 FY2023Sep 30, 2023$22.03K-93.0%
Q2 FY2023Jun 30, 2023$50.92K–
Q4 FY2022Dec 31, 2022$105.92K-13.0%
Q3 FY2022Sep 30, 2022$263.82K–
Q2 FY2022Jun 30, 2022$314.01K–
Q4 FY2021Dec 31, 2021$0–
Q4 FY2020Dec 31, 2020$121.70K–
Q4 FY2019Dec 31, 2019$0–

More Zivo Bioscience figures

See a number that looks wrong?